Search

everythinglearnresearchcommunity

for

Search:↓

Some hair loss and prostate drugs might increase the risk of diabetes and heart disease.

Finasteride and dutasteride might lower melanoma risk.

Older men should openly discuss sexual health with doctors to improve their quality of life.

Women have a higher risk of blood clots from hormonal factors and need careful treatment, especially during pregnancy.

Compound 7b is a promising candidate for treating benign prostatic hyperplasia and prostate cancer.

High uric acid can cause health problems, but lifestyle changes can help manage it.

Provenge extends prostate cancer survival by about 4 months.

5ARIs lower PSA levels, but other tests are needed to avoid missing aggressive prostate cancer.

5α-reductase inhibitors increase the risk of sexual dysfunction, especially in men with enlarged prostate.

Feeling younger can improve health and extend life.

Bald men should protect their scalps from the sun to reduce skin cancer risk.

Triple Hormonal Blockade (ADT3) can effectively manage prostate cancer but requires careful monitoring for heart risks.

Gender-affirming hormone therapy improves mental health and gender incongruence but requires careful management of cardiovascular and cancer risks.

Dihydrotestosterone (DHT) mainly affects nearby cells, doesn't significantly change prostate hormonal environment or cancer risk, and doesn't play a main role in causing hair loss or acne. More research is needed on its effects on heart health, sexual function, and bone health.

Men using 5-alpha reductase inhibitors for prostate issues may have a slightly higher risk of blood clots.

Men with less sun-sensitive skin have lower PSA levels, while men with more sun-sensitive skin have higher PSA levels.

The skin's internal clock affects healing, cancer risk, aging, immunity, and hair growth, and disruptions can harm skin health.

Flutamide combined with an LHRH agonist effectively inhibits prostate growth, suggesting it could treat prostate cancer.

5-alpha reductase inhibitors may cause sexual side effects, breast complications, and other health risks in men with hair loss.

Dutasteride effectively treats benign prostatic obstruction, improves urinary flow, reduces prostate size, and may prevent prostate cancer, but can cause sexual side effects.

Removing Sprouty genes in mice causes various hormone-related issues but does not increase cancer risk by one year of age.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Finasteride does not prevent bladder cancer.

Cancer rates are increasing in developed countries, with estrogen, aging, low vitamin D3, and HPV infection as common causes.

Researchers found 71 genetic regions linked to male pattern baldness, which account for 38% of its genetic risk.

Older adults have a high rate of skin cancers like basal cell carcinoma and melanoma, mainly due to UV exposure and age.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

Anabolic androgenic steroids can increase cancer risk and disrupt hormones.

Finasteride improves prostate cancer detection in PSA test.